Pfizer to acquire oncology specialist Medivation for $ 14 bn

Posted on:25 Aug 2016 09:34:58

Pfizer to acquire oncology specialist Medivation for $ 14 bn
25 August 2016 Current Affairs: The US-headquartered pharma major Pfizer Inc has entered into an agreement to acquire Medivation Inc, a biopharmaceutical company focused on developing and commercialising small molecules for oncology, for a total enterprise value of approximately $ 14 billion.

The merger will give a boost to Pfizer’s consolidation effort through a series of acquisitions, especially after its bid to take over Allergan Plc in a $150 billion deal late last year fell apart when the Obama administration prevented the proposed combination with new rules.


Subscribe to Current Affairs

Enter your email to get daily current affairs

Current Affairs July 2017

24 JULY
NEWS
22 JULY
NEWS
21 JULY
NEWS
20 JULY
NEWS

Current Affairs June 2017

30 JUNE
NEWS
29 JUNE
NEWS
28 JUNE
NEWS
27 JUNE
NEWS

Current Affairs May 2017

31 MAY
NEWS
30 MAY
NEWS
29 MAY
NEWS
27 MAY
NEWS